Jincheng Pharmaceutical announced that the holding subsidiary Jincheng Jinsu received a notice of approval for a supplementary application for injectable cefodizine sodium drugs issued by the State Drug Administration. The drug passed the consistent evaluation of the quality and efficacy of generic drugs. Cefodizin sodium for injection is a third-generation cephalosporin, mainly used for infections caused by sensitive bacteria such as streptococci and pneumococci. According to MineNet, domestic sales of full-standard injectable cefodizine sodium in public medicine from 2022 to 2024 were 1,074 million yuan, 675 million yuan, and 394 million yuan, respectively.

Zhitongcaijing · 07/01 10:17
Jincheng Pharmaceutical announced that the holding subsidiary Jincheng Jinsu received a notice of approval for a supplementary application for injectable cefodizine sodium drugs issued by the State Drug Administration. The drug passed the consistent evaluation of the quality and efficacy of generic drugs. Cefodizin sodium for injection is a third-generation cephalosporin, mainly used for infections caused by sensitive bacteria such as streptococci and pneumococci. According to MineNet, domestic sales of full-standard injectable cefodizine sodium in public medicine from 2022 to 2024 were 1,074 million yuan, 675 million yuan, and 394 million yuan, respectively.